Serinus Biosciences YC Application

Summer 2022Active

Serinus Biosciences went through Y Combinator in the Summer 2022 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.

YC batch: Summer 2022
Industry: HealthcareTherapeutics
Team size: 6
Status: Active
Launched: 2022

Founders

Adam YaariFounder/CEO
Maxwell ShermanFounder/CTO

What Serinus Biosciences does

Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.

Serinus Biosciences's YC application, reconstructed

Y Combinator application

Serinus Biosciences, Summer 2022 batch. The real form questions, answered from public data.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Serinus Biosciences

Describe what your company does in 50 characters or less.

Combinations therapy by rational design

What is your company going to make? Please describe your product and what it does or will do.

We are building an AI platform that designs combination therapies to overcome cancer treatment resistance. Our system uses decades of system biology knowledge to model how cancer evolves escape routes to therapies, allowing us to propose molecule combinations that are more effective and safer. The output is explainable, letting researchers and clinicians understand why the selected combinations work.

Where do you live now, and where would the company be based after YC?

We live and operate in New York, NY, USA, and plan to keep the company based here after YC.

Explain your decision regarding location.

New York is a biotech and healthcare innovation hub with access to top academic partners and talent. Staying here lets us collaborate closely with our scientific advisors and prospective customers while benefiting from YC's remote-friendly approach.

21 more answers in the full application

Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.

See full application

Frequently Asked Questions

Is this the real Serinus Biosciences YC application?

No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Serinus Biosciences's public data (launch notes, founder backgrounds, product description). It shows how a company like Serinus Biosciences would present itself to YC, not the text they submitted.